DAWN KORF: Open Payments
NPI 1427025170 · ROSWELL, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$781 in 38 payments from 7 companies in 2025. Trend: 2023 $671 · 2024 $930 · 2025 $781
Food & beverage: $681Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $270 |
| ABBVIE INC. | 10 | $193 |
| Regeneron Healthcare Solutions, Inc. | 6 | $119 |
| Galderma Laboratories, L.P. | 4 | $73 |
| Lilly USA, LLC | 3 | $73 |
| Amgen Inc. | 2 | $38 |
| GENZYME CORPORATION | 1 | $15 |
Products named: TREMFYA, DUPIXENT, RINVOQ, SKYRIZI, NEMLUVIO, TALTZ, OTEZLA, EBGLYSS.
Industry payments across NM — which companies pay providers there.
